Literature DB >> 11006973

In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke.

A Gerhard1, B Neumaier, E Elitok, G Glatting, V Ries, R Tomczak, A C Ludolph, S N Reske.   

Abstract

Neuroprotective strategies are currently being developed for stroke patients. Although the focus is on the development of early treatment the importance of late pathogenetic events is increasingly recognized. To investigate the microglial reaction in stroke we used a marker for activated microglia, [11C]PK11195, and PET in five patients with ischemic stroke 5-53 days after infarction. In one patient serial measurements were made. We demonstrated in each individual and at each point in time that a microglial reaction takes place in the area where T1 weighted MRI (magnetic resonance imaging) shows intensity changes. We consider this PET method as a promising tool to study the late pathogenetic consequences of cerebral infarction and to evaluate neuroprotective strategies with respect to the consequences of the microglial activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006973     DOI: 10.1097/00001756-200009110-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  46 in total

Review 1.  Human cellular inflammation in the pathology of acute cerebral ischaemia.

Authors:  C J S Price; E A Warburton; D K Menon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 2.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

3.  PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06.

Authors:  Frederick M Lartey; G-One Ahn; Bin Shen; Keith-Travis Cord; Tenille Smith; Joshua Y Chua; Sahar Rosenblum; Hongguang Liu; Michelle L James; Sophia Chernikova; Star W Lee; Laura J Pisani; Rabindra Tirouvanziam; John W Chen; Theo D Palmer; Frederick T Chin; Raphael Guzman; Edward E Graves; Billy W Loo
Journal:  Mol Imaging Biol       Date:  2013-07-09       Impact factor: 3.488

4.  The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.

Authors:  Sriram Venneti; Guoji Wang; Jason Nguyen; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

5.  Transient focal ischemia results in persistent and widespread neuroinflammation and loss of glutamate NMDA receptors.

Authors:  Jasbeer Dhawan; Helene Benveniste; Marta Nawrocky; S David Smith; Anat Biegon
Journal:  Neuroimage       Date:  2010-03-04       Impact factor: 6.556

Review 6.  Inflammatory mechanisms in ischemic stroke: role of inflammatory cells.

Authors:  Rong Jin; Guojun Yang; Guohong Li
Journal:  J Leukoc Biol       Date:  2010-02-03       Impact factor: 4.962

7.  Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.

Authors:  Pablo M Rusjan; Alan A Wilson; Peter M Bloomfield; Irina Vitcu; Jeffrey H Meyer; Sylvain Houle; Romina Mizrahi
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-27       Impact factor: 6.200

Review 8.  Treatment of amyotrophic lateral sclerosis--what is the next step?

Authors:  A C Ludolph
Journal:  J Neurol       Date:  2000-12       Impact factor: 4.849

Review 9.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

10.  [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis.

Authors:  Janine Doorduin; Hans C Klein; Rudi A Dierckx; Michelle James; Michael Kassiou; Erik F J de Vries
Journal:  Mol Imaging Biol       Date:  2009-03-28       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.